Nucleic acid transfer vector for the introduction of nucleic...

Details Nucleic acid transfer vector for the introduction of nucleic... Nucleic acid transfer vector for the introduction of nucleic...

2006-12-12

2006-12-12

Woitach, Joseph (Department: 1632)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C536S023100, C536S023400, C536S023500, C536S024100, C435S325000

Reexamination Certificate

active

07148203

ABSTRACT:
This invention relates to a system for introducing nucleic acid into the DNA of a cell. The system includes the use of a member of the SB family of transposases (SB) or nucleic acid encoding the transposase and a nucleic acid fragment that includes a nucleic acid sequence with flanking inverted repeats. The transposase recognizes at least a portion of an inverted repeats and incorporates the nucleic acid sequence into the DNA. Methods for use of this system are discussed.

REFERENCES:
patent: 4631259 (1986-12-01), Clewell et al.
patent: 5464758 (1995-11-01), Gossen et al.
patent: 5595889 (1997-01-01), Richaud et al.
patent: 5677170 (1997-10-01), Devine et al.
patent: 5719055 (1998-02-01), Cooper
patent: 5814618 (1998-09-01), Bujard et al.
patent: 5879933 (1999-03-01), Hodgson
patent: 5928888 (1999-07-01), Whitney
patent: 5948681 (1999-09-01), Scanlin et al.
patent: 6013240 (2000-01-01), Behr
patent: 6051430 (2000-04-01), Plasterk et al.
patent: 6225121 (2001-05-01), Savakis et al.
patent: 6489458 (2002-12-01), Hackett et al.
patent: 6613752 (2003-09-01), Kay et al.
patent: 2002/0016975 (2002-02-01), Hackett et al.
patent: 2002/0103152 (2002-08-01), Kay et al.
patent: 2005/0003542 (2005-01-01), Kay et al.
patent: 0 485 701 (1992-05-01), None
patent: 0 756 007 (1997-01-01), None
patent: WO 88/01646 (1988-03-01), None
patent: WO 93/04701 (1993-03-01), None
patent: WO 93/25239 (1993-12-01), None
patent: WO 95/01095 (1995-01-01), None
patent: WO 96/01313 (1996-01-01), None
patent: WO 96/40892 (1996-12-01), None
patent: WO 97/15679 (1997-05-01), None
patent: WO 97/29202 (1997-08-01), None
patent: WO 98/24479 (1998-06-01), None
patent: WO 98/40510 (1998-09-01), None
patent: WO 98/56903 (1998-12-01), None
patent: WO 99/25817 (1999-05-01), None
patent: WO 99/59546 (1999-11-01), None
patent: WO 00/30687 (2000-06-01), None
patent: WO 00/68399 (2000-11-01), None
patent: WO 01/30965 (2001-05-01), None
patent: WO 02/13602 (2001-06-01), None
patent: WO 01/81565 (2001-11-01), None
patent: WO 01/89579 (2001-11-01), None
patent: WO 01/91802 (2001-12-01), None
patent: WO 01/89579 (2002-08-01), None
Adey et al., “Molecular resurrection of an extinct ancestral promoter for mouse L1,”Proc. Natl. Acad. Sci. USA,91, 1569-1573 (1994).
Allende et al., “Insertional mutagenesis in zebrafish identifies two novel genes, pescadillo and dead eye, essential for embryonic development,”Genes Dev., 10, 3141-3155 (1996).
Amsterdam et al., “TheAequorea victoriagreen fluorescent protein can be used as a reporter in live zebrafish embryos,”Dev Biol., 171(1):123-9 (1995).
Anderson et al., “Gene expression in rainbow trout (Oncorhynchus mykiss) following intramuscular injection of DNA,”Mol. Mar. Biol. Biotech., 5, 105-113 (1996).
Ausubel,Current Protocols in Molecular Biology, Contents: Vols. 1,2, and 3, Tables of Contents (1994).
BD Biosciences Clontech Company, “Bidirectional Tet Expression Vectors, Simultaneously control expression of two genes with one tet-responsive element,” [online] Palo Alto, CA [retrieved on Apr. 25, 2000]. Retrieved from the Internet: <http://www.clontech.com/archive/OCT96UPD/pBIVectors.html>; 3 pages.
BD Biosciences Clontech Company, “Tet Expression Systems & Cell Lines, Mammalian cell cultures systems for tightly regulated, high-level gene expression,” [online] Palo Alto, CA [retrieved on May 30, 2000]. Retrieved from the Internet: <http://www.clontech.com/archive/JUL96UPD/Tet.html>, 6 pages.
BD Biosciences Clontech Company, “Tet System Vectors & Primers, Complete your Tet Systems tool kit with individual regulator and selection plasmids,” [online] Palo Alto, CA [retrieved on Apr. 23, 2000]. Retrieved from the Internet: <http://www.clontech.com/archive/OCT96UPD/TetVectors.html>, 3 pages.
Ballinger et al., “Targeted gene mutations in Drosophila,”Proc. Natl. Acad. Sci. USA, 86, 9402-9406 (1989).
Bandyopadhyay et al., “Enhanced gene transfer into HuH-7 cells and primary rat hepatocytes using targeted liposomes and polyethylenimine,”Biotechniques. 25(2):282-92 (Aug. 1998).
Bandyopadhyay et al., “Nucleotide exchange in genomic DNA of rat hepatocytes using RNA/DNA oligonucleotides. Targeted delivery of liposomes and polyethyleneimine to the asialoglycoprotein receptor,”J Biol Chem., 274(15):10163-72 (1999).
Bayer et al., “A transgene containingIacZis expressed in primary sensor neurons in zebrafish,”The Company of Biologists Limited, 115:421-426 (1992).
Becker et al., “Chapter 8: Use of Recombinant Adenovirus for Metabolic Engineering of Mammalian Cells,” Methods in Cell Biology, vol. 43: Protein Expression in Animal Cells, Roth, ed., Academic Press, New York, Title page, publication page, table of contents and pp. 161-189 (1994).
Beckwith, “Iac: The Genetic System,” The Operon, second edition, Miller et al., eds., Cold Spring Harbor Laboratory Press, New York, Title page, publication page, table of contents, and pp. 11-30 (1980).
Bellen et al., “P-element-mediated enhancer detection: a versatile method to study development in Drosophila,”Genes Dev., 3, 1288-1300 (1989).
Bellon et al., “Aerosol Administration of a Recombinant Adenovirus Expressing CFTR to Cystic Fibrosis Patients: A Phase I Clinical Trial,”Human Gene Ther., 8(1):15-25 (1997).
Bingham et al., “Cloning of DNA Sequences from the white Locus of D. melanogaster by a Novel and General Method,”Cell, 25, 693-704 (1981).
Blazar et al., “In uterotransfer of adult bone marrow cells into recipients with severe combined immunodeficiency disorder yields lymphoid progeny with T- and B-cell functional capabilities,”Blood, 86(11):4353-66 (1995).
Bonaldo et al., “Efficient Gene Trap Screening for Novel Developmental Genes Using IRESβgeo Vector andin VitroPreselection,”Experimental Cell Research, 244, 125-136 (1998).
Borman et al., “Comparison of picornaviral IRES-driven internal initiation of translation in cultured cells of different origins,”Nucleic Acids Res., 25, 925-932 (1997).
Borman et al., “Picornavirus internal ribosome entry segments: comparison of translation efficiency and the requirements for optimal internal initiation of translationin vitro,” Nucleic Acids Res.,23, 3656-3663 (1995).
Bosma et al., “Bilirubin UDP-glucuronosyltransferase 1 is the Only Relevant Bilirubin Glucuronidating Isoform in Man,”J. Biol. Chem.,269, 17960-17964 (1994).
Boussif et al., “A versatile vector for gene and oligonucleotide transfer into cells in culture andin vivo: polyethylenimine,”Proc. Natl. Acad. Sci. USA, 92(16):7297-301 (1995).
Bradley et al., “Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines,”Nature, 309, 255-256 (1984).
Bragonzi et al., “Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs,”Gene Ther.,6, 1995-2004 (1999).
Burcin et al., “Adenovirus-mediated regulable target gene expressionin vivo,” Proc. Nat'l. Acad. Sci. USA,96:355-360 (Jan. 19, 1999).
Caldovic et al., “Development of position-independent expression vectors and their transfer into transgenic fish,”Molecular Marine Biology and Biotechnology, 4, 51-61 (1995).
Carey, “On the Trail of the Jumping Genes,”Business Week, p. 89 (Jun. 29, 1998).
Choi et al., “Lactose-Poly(ethylene Glycol)-Grafted Poly-L-Lysine as Hepatoma Cell-Targeted Gene Carrier,”Bioconjugate Chem.,9:708-718 (1998).
Chowdhury et al., “Isolation of Multiple Normal and Functionally Defective Forms of Uridine Diphosphate-Glucuronosyltransferase from Inbred Gunn Rats,”J. Clin. Invest.,79, 327-334 (1987).
Chowdhury et al., “Gunn rat: a model for inherited deficiency of bilirubin glucuronidation,”Adv. Vet. Sci. Comp. Med.,37:149-73 (1993).
Clark et al., “Development of Dicistronic Vect

Affiliated with

Also associated with

Rating

Nucleic acid transfer vector for the introduction of nucleic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleic acid transfer vector for the introduction of nucleic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid transfer vector for the introduction of nucleic... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3705576